Mesoblast shares plunge after FDA questions treatment

MELBOURNE: Shares in Stem-cell focused biotech Mesoblast dived more than 30 per cent ... read more

Atomo climbs 16pc after TGA test approval

MELBOURNE: The healthcare community and broader market initially misunderstood the role of Atomo ... read more

Qantas share purchase plan falls flat with investors

SYDNEY: Qantas and its investors are playing down the significance of a $430 ... read more

Monadelphous hit by downgrades with dividend now effected

MELBOURNE: Shares in mining services company Monadelphous dropped as much as 5.2 per ... read more